Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Down 39.2% in August

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 30,384 shares, a decrease of 39.2% from the July 30th total of 49,986 shares. Based on an average daily trading volume, of 35,912 shares, the short-interest ratio is presently 0.8 days. Currently, 0.8% of the company’s shares are short sold.

Institutional Investors Weigh In On Invesco Pharmaceuticals ETF

Several institutional investors have recently made changes to their positions in PJP. Fifth Third Bancorp purchased a new position in shares of Invesco Pharmaceuticals ETF during the 1st quarter worth about $36,000. Global Assets Advisory LLC purchased a new stake in Invesco Pharmaceuticals ETF in the 1st quarter worth about $42,000. IFP Advisors Inc lifted its stake in Invesco Pharmaceuticals ETF by 31.3% in the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock worth $46,000 after purchasing an additional 105 shares during the last quarter. International Assets Investment Management LLC bought a new stake in Invesco Pharmaceuticals ETF in the fourth quarter worth about $64,000. Finally, Rockefeller Capital Management L.P. lifted its stake in Invesco Pharmaceuticals ETF by 20.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock worth $129,000 after purchasing an additional 209 shares during the last quarter.

Invesco Pharmaceuticals ETF Stock Up 0.8%

PJP traded up $1.02 during trading on Wednesday, reaching $129.04. The company had a trading volume of 20,649 shares, compared to its average volume of 35,494. The stock has a market cap of $495.51 million, a P/E ratio of 15.59 and a beta of 0.45. The business has a 50 day simple moving average of $122.71 and a 200-day simple moving average of $112.34. Invesco Pharmaceuticals ETF has a 52 week low of $90.01 and a 52 week high of $131.68.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.